US WM patients currently in treatment, scheduled to start treatment, or being monitored by a doctor are eligible for a one-time $100 payment from an LLS support program.
Dr. Herbert Eradat’s (UCLA) presentation at the 2018 LRF Ed Forum, “WM: An Overview and Update on Advances and Novel Treatments,” is now available for viewing online.
The Mayo Clinic is holding a special patient event on March 16, 2019 to honor Dr. Kyle. Come and hear the latest on WM, including a presentation from the legendary Dr. Kyle.
Stephen was diagnosed in 1998 at the age of 63 and treated sequentially with 4 different drugs over 3 1/2 years. He’s been on watch and wait since his last treatment in 2001.
The LLS recently increased the co-pay assistance amount available for US WM patients to $7,500 to help defray medical costs.
The WhiMSICAL patient registry has a new set of questions that will enable researchers to map quality of life (QoL) data to treatments.
Mark your calendars for June 7-9, 2019, in Philadelphia, PA, as this will be your opportunity to learn from top researchers and clinicians, fellow patients, and caregivers.
On November 15, 2018, the IWMF issued an RFP to 273 of the leading WM researchers in the world. This RFP was developed together with the Leukemia & Lymphoma Society (LLS).
Tom Hoffmann, MD, retired cardiovascular surgeon and current IWMF Board Member, has been elected to serve as the IWMF’s Vice President for Research.
Find out what a specialty pharmacy is, how it differs from a regular pharmacy, what it has to offer, and why you might need one someday.